TrialHaematologica2025

Chemotherapy-free combination of ibrutinib and obinutuzumab for untreated advanced follicular lymphoma: results of a phase II study from the German Lymphoma Alliance.

Christian Schmidt et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.